Today, the U.S. Court of Appeals for the Second Circuit will hear oral arguments in the case of Haller v. Health and Human Services (HHS) and decide whether or not to uphold the U.S. District Court’s ruling preserving the No Surprises Act (NSA), legislation that prohibits patients from receiving surprise bills for unexpected out-of-network costs.
ALBANY, NY – DECEMBER 22, 2023 – Today, Governor Kathy Hochul signed Senate Bill 1196a / Assembly Bill 1673a into law, securing a major win for patients across New York.
TALLAHASSEE, Fla. – Rep. Karen Gonzalez Pittman (R-Tampa) and Sen.
TRENTON, NJ – DECEMBER 13, 2023 – A new poll reveals that Philadelphia-area adults living in both Pennsylvania and New Jersey are much more likely to visit Atlantic City casinos if they are 100% smoke-free.
Today, the American Cancer Society Cancer Action Network joined 21 groups representing millions of cancer patients, survivors and caregivers, to send a letter to the White House supporting the U.S. Food and Drug Administration proposed rules to eliminate the sale of menthol in cigarettes and all flavors in cigars.
ALBANY, NY – DECEMBER 13, 2023 – The New York State Legislature has sent Senate Bill 1196a / Assembly Bill 1673a to the Governor’s desk, giving her 10 days to take action on the legislation.
TRENTON, NJ – DECEMBER 13, 2023 – Earlier today, Senate Health, Human Services & Senior Citizens Committee Chair Joe Vitale pulled the smoke-free proposal off the agenda for tomorrow’s committee hearing, citing a lack of support from committee members.
The American Cancer Society Cancer Action Network (ACS CAN) condemns the House for not standing up for the health of Ohioans and putting our children at greater risk of becoming Big Tobacco’s next customers. Instead of offering solutions to address the health of our residents, lawmakers have now limited what local governments can do to prevent people from starting to use tobacco and help people quit.
The National Institutes of Standards and Technology proposed new guidance late last week that seeks to expand conditions under which federal government agencies can apply march-in rights, a provision of the 1980 Bayh-Doyle Act, to include consideration for pricing of pharmaceutical drugs.